MAIA Biotechnology (MAIA) Stock Price, Quote, News & History

MAIA Biotechnology Inc (MAIA) Stock Price, Quote, News & History

MAIAAMEX

Trade with Public

$1.54

0.010.65%

At close: Mar 16, 5:00 PM EST

$1.53

-0.01-0.65%

After Hours: 6:39 PM EST

Key Statistics

Open

$1.52

$1.54

Volume / Avg.

661.10K / 1.05M

Day Range

$1.48 - $1.54

52 Wk Range

0.87 - 3.19

Market Cap

$89.75M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

4.55%

Days to Cover

3.78

Recent Maia Biotechnology Inc News

Is the Market Bullish or Bearish on MAIA Biotechnology Inc?

Benzinga Insights

PRO
On March 2, 2026, MAIA Biotechnology Entered Into An Underwriting Agreement With Konik Capital Partners; To Issue 20,000,000 Shares Of Common Stock In Public Offering

-SEC Filing

Benzinga Newsdesk

PRO
Reported Earlier, MAIA Biotechnology Raises $30M Through 20M Common Share Public Offering At $1.50 Per Share To Fund Cancer Immunotherapy Clinical Trials

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.73M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

17.95M

Free Cash Flow (TTM)

-15.73M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

2.22M

Valuation Metrics

Enterprise Value

$78.86M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

2153.81

Earnings Yield % (TTM)

-48.37%

Earnings Yield % (FWD)

-45.10%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$10.89M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.52

$1.54

Volume / Avg.

661.10K / 1.05M

Day Range

$1.48 - $1.54

52 Wk Range

0.87 - 3.19

Market Cap

$89.75M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

4.55%

Days to Cover

3.78

About

Sector

Health Care

Industry

Biotechnology

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorpor...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MAIA Biotechnology (MAIA) stock?

You can purchase shares of MAIA Biotechnology (AMEX:MAIA) through any online brokerage.

View our list of the best stock brokerages

Who are MAIA Biotechnology (MAIA) competitors?

Other companies in MAIA Biotechnology’s space includes: Fortress Biotech Inc (NASDAQ:FBIO), Anixa Biosciences Inc (NASDAQ:ANIX), Gain Therapeutics Inc (NASDAQ:GANX), Inovio Pharmaceuticals Inc (NASDAQ:INO) and Citius Oncology Inc (NASDAQ:CTOR).

What is the forecast, or price target, for MAIA Biotechnology (MAIA) stock?

There is no analysis for MAIA Biotechnology to provide a consensus price target.

What is the current price for MAIA Biotechnology (MAIA)?

The stock price for MAIA Biotechnology (AMEX: MAIA) is $1.53 last updated March 16, 2026 at 6:39 PM EDT.

Does MAIA Biotechnology (MAIA) pay a dividend?

There are no upcoming dividends for MAIA Biotechnology.

When is MAIA Biotechnology (AMEX:MAIA) reporting earnings?

MAIA Biotechnology does not have any upcoming earnings scheduled.

Is MAIA Biotechnology (MAIA) going to split?

There is no upcoming split for MAIA Biotechnology.

What sector and industry does MAIA Biotechnology (MAIA) operate in?

MAIA Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch

Anixa Biosciences Inc

NASDAQ:ANIX

$2.81

-1.11%

Gain Therapeutics Inc

NASDAQ:GANX

$2.57

1.98%

Inovio Pharmaceuticals Inc

PMV Pharmaceuticals Inc

NASDAQ:PMVP

$1.56

Key Statistics

Open

$1.52

$1.54

Volume / Avg.

661.10K / 1.05M

Day Range

$1.48 - $1.54

52 Wk Range

0.87 - 3.19

Market Cap

$89.75M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

4.55%

Days to Cover

3.78

Recent Maia Biotechnology Inc News

Is the Market Bullish or Bearish on MAIA Biotechnology Inc?

Benzinga Insights

PRO
On March 2, 2026, MAIA Biotechnology Entered Into An Underwriting Agreement With Konik Capital Partners; To Issue 20,000,000 Shares Of Common Stock In Public Offering

-SEC Filing

Benzinga Newsdesk

PRO
Reported Earlier, MAIA Biotechnology Raises $30M Through 20M Common Share Public Offering At $1.50 Per Share To Fund Cancer Immunotherapy Clinical Trials

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.73M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

17.95M

Free Cash Flow (TTM)

-15.73M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

2.22M

Valuation Metrics

Enterprise Value

$78.86M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

2153.81

Earnings Yield % (TTM)

-48.37%

Earnings Yield % (FWD)

-45.10%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$10.89M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$1.52

$1.54

Volume / Avg.

661.10K / 1.05M

Day Range

$1.48 - $1.54

52 Wk Range

0.87 - 3.19

Market Cap

$89.75M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

4.55%

Days to Cover

3.78

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry